← Evidence map

ReviewAntioxidants & redox signaling2017

Clinically Evaluated Cancer Drugs Inhibiting Redox Signaling.

D Lynn Kirkpatrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26983373